Skip to main content
. 2021 Nov 2;21:1130. doi: 10.1186/s12879-021-06816-y

Table 3.

Definition of warning signs

Warning signs Physicians (186) Frequency (Percent) Nurses (285) Frequency (Percent) P-value
Abdominal pain
 Abdominal tenderness 85 (45.7) 93 (32.6) 0.005
 Continuous abdominal pain 93 (50.0) 107 (37.5) 0.007
 Increasing pain 70 (37.6) 132 (46.3) 0.06
 Do not know/Not sure 7 (3.8) 47 (16.5) < 0.0001
Persistent vomiting
 ≥ 6 episodes of vomiting in 24 h 37 (19.9) 51 (17.9) 0.6
 ≥ 5 episodes of vomiting in 24 h 29 (15.6) 28 (9.8) 0.06
 ≥ 3 episodes of vomiting in 1 h 52 (28.0) 82 (28.8) 0.9
 Vomiting for ≥ 2 consecutive days 46 (27.4) 103 (36.1) 0.05
 Vomiting with signs of dehydration on physical examination 55 (29.6) 79 (27.7) 0.7
 Vomiting whenever eating/drinking 45 (24.2) 55 (19.3) 0.2
 Do not know/Not sure 17 (9.1) 40 (14.0) 0.1
Mucosal bleeding
 Epistaxis 149 (80.1) 199 (69.8) 0.01
 Gingival bleeding 149 (80.1) 237 (83.2) 0.4
 Hematemesis, Melena 123 (66.1) 172 (60.4) 0.2
 Hemoptysis 58 (31.2) 46 (16.1) 0.0001
 Ear bleeding 42 (22.6) 36 (12.6) 0.004
 Hematuria 94 (50.5) 72 (25.3) < 0.0001
 Menorrhagia, metrorrhagia, vaginal bleeding 116 (62.4) 152 (53.3)
 Petechia, purpura, ecchymosis, bruises 72 (38.7) 154 (54.0) 0.05
 Conjunctival, subconjunctival, retinal hemorrhages 108 (58.1) 138 (48.4) 0.03
Plasma leakage
 Hemoconcentration 162 (87.1) 218 (76.5) 0.005
 Pleural effusion 130 (69.9) 157 (55.1) 0.001
 Gall bladder thickening 95 (51.1) 64 (22.5) < 0.0001
 Ascites 101 (54.3) 97 (34.0) < 0.0001
 Edema (face and extremities) 64 (34.4) 66 (23.2) 0.009
 Free fluids around the urinary bladder
 Do not know/Not sure 4 (2.2) 26 (9.1) 0.003
Liver enlargement
 Liver edge palpated more than 2 cm below the costal margin 107 (57.5) 129 (45.3) 0.009
 Liver edge palpated below the costal margin 33 (17.7) 81 (28.4) 0.008
 Painful hepatomegaly 120 (64.5) 151 (53.0) 0.01
 Depend on each case 27 (14.5) 70 (24.6) 0.008
Hemoconcentration
 Increasing in hematocrit by more than 20% from the baseline 133 (72.7) 158 (57.5) 0.0008
 Increasing in hematocrit by more than 15% from the baseline 15 (8.2) 25 (9.1) 0.7
 Using a cutoff value for hematocrit that is adjusted for gender 11 (6.0) 12 (4.4) 0.4
 Using a non-adjusted cutoff value of hematocrit > 48%, with no discrimination between males and females 10 (5.5) 25 (9.1) 0.1
 Do not know/Not sure 14 (7.7) 55 (20.0) 0.0003
Rapid decrease in platelet count
 < 20.000 mm3 (1) 17 (9.4) 19 (7.0) 0.3
 < 50.000 mm3 (2) 43 (23.9) 36 (13.2) 0.003
 < 100.000/ mm3 (3) 78 (43.3) 151 (55.5) 0.009
 < 150.000/ mm3 (4) 4 (2.2) 12 (4.4) 0.2
 Do not know/Not sure 38 (21.1) 54 (19.9) 0.7
Lethargy
 Alteration of consciousness and/or Glasgow score < 15 or Blantyre score less than 5 37 (20.2) 51 (18.2) 0.6
 Drowsiness and/or irritability 92 (50.3) 157 (56.1) 0.2
 Do not know/Not sure 54 (29.5) 72 (25.7) 0.3